Treatment Updates

Improving Survival in Colorectal Cancer Through Optimal Management of Liver Metastases

Module

• Liver Metastases in Colorectal Cancer: Improving Survival Through Optimal Management

Interactive Case Challenges

• Management of Initially Unresectable Liver Metastases in a 65-Year-Old Woman With Colorectal Cancer
• A 52-Year-Old Man With Colon Cancer and Resectable Metachronous Liver Metastases (coming soon)
• A 63-Year-Old Woman With Colorectal Cancer and Metachronous Liver and Lung Metastasis (coming soon)

Challenging the Dogma: Questioning the Role of Anthracyclines in Early Breast Cancer

Virtual Presentation

• Challenging the Dogma: Questioning the Role of Anthracyclines in Early Breast Cancer
• Challenging the Dogma: Questioning the Role of Anthracyclines in Early Breast Cancer

Audio Archive of Teleconference

Managing Ovarian Cancer Recurrence: Coupling Novel Therapeutics With Optimal Treatment Decisions

Modules

• Current Standards in Recurrent Ovarian Cancer
• Clinical Potential of Novel Cytotoxic and Biologic Agents in Ovarian Cancer (coming soon)
• Current Issues and Controversies in the Treatment of Recurrent Ovarian Cancer (coming soon)

Clinical Controversies in the Treatment of Anemia: Appropriate Use of ESAs in a Time of Change

Slideset Module

• Clinical Controversies in the Treatment of Anemia: Appropriate Use of ESAs in a Time of Change
• Clinical Controversies in the Treatment of Anemia: Appropriate Use of ESAs in a Time of Change

Advances in Lymphoproliferative Disease: From Molecular Pathogenesis to Multitargeted Treatment

Modules and Slidesets

• Pathogenesis and Progression of Lymphoproliferative Disease: Evolving Concepts (coming soon)
• Cytotoxic Chemotherapy in a Time of Change
• Cytotoxic Chemotherapy in a Time of Change
• Monoclonal Antibodies in Lymphoproliferative Disorders: From Rationale to Results
• Monoclonal Antibodies in Lymphoproliferative Disorders: From Rationale to Results
• Mechanism Based Therapies for the Treatment of Lymphoid Leukemias
• Mechanism Based Therapies for the Treatment of Lymphoid Leukemias
• Advances in Targeted Therapies for the Treatment of Non-Hodgkin’s Lymphomas
• Advances in Targeted Therapies for the Treatment of Non-Hodgkin’s Lymphomas
• Debate Session – Strategic Approaches to Therapy: Advances and Challenges

Translating Science Into Clinical Practice: Recent Lessons in EGFR Inhibition, Multitargeted TKIs, and the Tumor Microenvironment

Modules

• Targeting Multiple Pathways in the Treatment of Cancer
• EGFR-Targeted Antibodies: Clinical Applications, Treatment Challenges, and Ongoing Scientific Research
• Multitargeted Tyrosine Kinase Inhibitors: Clinical Advances, Synergistic Approaches, and Future Development
• Targeting the Tumor Microenvironment: Ongoing Research, Clinical Updates, and Promising Applications (coming soon)

CCO Slidesets

• Targeting Multiple Pathways in the Treatment of Cancer
• EGFR-Targeted Antibodies: Clinical Applications, Treatment Challenges, and Ongoing Scientific Research
• Multitargeted Tyrosine Kinase Inhibitors: Clinical Advances, Synergistic Approaches, and Future Development
• Targeting the Tumor Microenvironment: Ongoing Research, Clinical Updates and Promising Applications

Novel Approaches in Frontline Multiple Myeloma Therapy: Understanding the Options and Implications for Transplantation

Module

• Advances in the Frontline Treatment of Multiple Myeloma

Interactive Case Challenges

• Clinical Management of a 59-Year-Old Male Patient With Multiple Myeloma and Renal Dysfunction
• Management of a Transplantation-Eligible 58-Year-Old Male With Newly Diagnosed Multiple Myeloma
• Treatment of Newly Diagnosed Multiple Myeloma in a 78-Year-Old Woman

CCO Slideset

• Advances in the Frontline Treatment of Multiple Myeloma

Attacking the Signal at the Switch: Unraveling the Mysteries of mTOR Inhibition in Multiple Tumor Types

Modules

• What Is the Rationale for Exploring mTOR Inhibition?
• Confirming the Role of mTORs in Oncology: Treatment of Renal Cell Carcinoma
• mTOR Inhibition in Solid Tumors: Emerging Data and Ongoing Trials
• Clinical Application in Hematologic Malignancies: Potential of mTOR Inhibitors
• mTOR Inhibitors in Practice: Clinical Implications and Future Considerations

Clinical Issues and Future Directions in Hematologic Malignancies

Virtual Presentations

• Multiple Myeloma
• Clinical Issues and Future Directions in Hematologic Malignancies: Multiple Myeloma
• Non-Hodgkin’s Lymphoma
• Non-Hodgkin’s Lymphoma
• Acute Leukemias
• Clinical Issues and Future Directions in Hematologic Malignancies: Acute Leukemias
• Myelodysplastic Syndromes
• Myelodysplastic Syndromes
• Chronic Myeloid Leukemia
• Chronic Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Clinical Issues and Future Directions in Hematologic Malignancies: Chronic Lymphocytic Leukemia

Master Class in Management of Liver Metastases From Colorectal Cancer

Virtual Presentation

• Master Class in Management of Liver Metastases From Colorectal Cancer: Case-Based Learning
• Master Class in Management of Liver Metastases from Colorectal Cancer: Case-Based Learning

Treatment Challenges in Myelodysplastic Syndromes

Module

• Insights Into the Pathogenesis, Classification, and Treatment of Myelodysplastic Syndromes

Interactive Case Challenges

• Clinical Management of a 69-Year-Old Man With Intermediate-1-Risk Myelodysplastic Syndrome
• Management of a 69-Year-Old Patient With Deletion 5q Myelodysplastic Syndrome
• Treatment of a 52-Year-Old Man With High-Risk Myelodysplastic Syndrome

Optimizing Treatment Choices in Ovarian Cancer

Virtual Presentations

• Early Detection and Treatment of Ovarian Cancer
• The Importance of Early Detection and Treatment of Ovarian Cancer
• Current Controversies in the Management of Recurrent Ovarian Cancer
• Current Controversies in the Management of Recurrent Ovarian Cancer
• New Agents for the Management of Ovarian Cancer
• New Agents for the Management of Ovarian Cancer

Practical Answers to Key Clinical Challenges: Optimizing Patient Outcomes in Breast Cancer

Module

• Practical Answers to Key Clinical Challenges: Optimizing Patient Outcomes in Breast Cancer

CCO Slideset

• Practical Answers to Key Clinical Challenges: Optimizing Patient Outcomes in Breast Cancer

Advances in Metastatic Colorectal Cancer: Molecular Pathways, Biomarkers, and Clinical Results

Virtual Presentations

• Update on the Science of Current Therapy for Metastatic Colorectal Cancer
• Update on the Science of Current Therapy for Metastatic Colorectal Cancer
• Controversies in Care: Using Clinical Data to Guide Treatment Selection
• Controversies in Care: Using Clinical Data to Guide Treatment Selection
• Exploring Biomarkers and Surrogates in Optimizing Patient Outcomes
• Exploring Biomarkers and Surrogates in Optimizing Patient Outcomes
• Potentially Curable Metastatic Disease in Colorectal Cancer: Neoadjuvant Approach to Liver-Limited Disease
• Potentially Curable Metastatic Disease in Colorectal Cancer: Neoadjuvant Approach to Liver-Limited Disease

Melanoma Treatment Update

Modules

• Genetics and Molecular Pathogenesis of Melanoma: Current Understanding
• Melanoma Diagnosis and Staging: Evolving Practice
• Treatment of Melanoma: Current Best Practice
• Exploring New Directions in Melanoma Treatment

Expert Reviews: Treatment Developments in GI Cancers

CCO Slideset

• Expert Reviews: Treatment Developments in Gastrointestinal Cancers

Downloadable Audio Recording of Teleconference

6th International Symposium on Translational Research in Oncology

Slideset Modules

• Session I: Growth Factors and Growth Factor Receptors
• Session I: Growth Factors and Growth Factor Receptors
• Session II: Steroid Hormonal Receptors and Their Manipulation
• Session II: Steroid Hormonal Receptors and Their Manipulation
• Session III: Apoptosis and Programmed Cell Death
• Session III: Apoptosis and Programmed Cell Death
• Session IV: Malignant Angiogenesis and Antiangiogenic Therapies
• Session IV: Malignant Angiogenesis and Antiangiogenic Therapies
• Session V: Signal Transduction: Targets in the Malignant Signaling Process
• Session V: Signal Transduction: Targets in the Malignant Signaling Process
• Session VI: Immunotherapies and Vaccine Strategies
• Session VI: Immunotherapies and Vaccine Strategies
• Session VII: Malignant Stem Cells as Targets in Oncology
• Session VII: Malignant Stem Cells as Targets in Oncology
• Session VIII: New Approaches to Pathway Identification, Predictive/Prognostic Factors, and Biologic Imaging Markers
• Session VIII: New Approaches to Pathway Identification, Predictive/Prognostic Factors, and Biologic Imaging Markers

Treatment Options in Colon and Rectal Cancers: The Role of Oral Therapy

Modules

• Update on the Use of Oral Therapies in Colon and Rectal Cancers

Interactive Case Challenges

• Management of a 65-Year-Old Male With Metastatic Colorectal Cancer and Gilbert's Syndrome
• Treatment of a 62-Year-Old Male With Locally Advanced Rectal Cancer
• Adjuvant Treatment in a 74-Year-Old Male With Stage III Colorectal Cancer

Tumor Immunology: Treatment Approaches With Immunotherapies in Human Cancer

Modules

• Immunology for the Oncologist: Historical Review of Immune Dysregulation and Immune Strategies
• Current Challenges in Cancer Immunotherapy
• New Directions in Cancer Immunotherapy

CCO Slideset

• Evolving Approaches in Cancer Immunotherapy

Advances in the Treatment of Lymphoproliferative Malignancies: Promising Directions in Mantle Cell Lymphoma, Follicular Lymphoma, and Waldenstrom’s Macroglobulinemia

Modules

• Mantle Cell Lymphoma: State of the Art
• The Evolving Role of Transplantation in Lymphoproliferative Malignancies
• Follicular Lymphoma: State of the Art
• Novel Therapies for Waldenstrom’s Macroglobulinemia

CCO Slidesets

• Mantle Cell Lymphoma: State of the Art
• The Evolving Role of Transplantation in Lymphoproliferative Malignancies
• Follicular Lymphoma: State of the Art
• Novel Therapies of Waldenstrom’s Macroglobulinemia

Anthracyclines in the Treatment of Multiple Myeloma: Traditional and Evolving Roles

Module

• Anthracyclines in the Treatment of Multiple Myeloma: Traditional and Evolving Roles

Interactive Case Challenges

• Anthracycline Therapy in a 55-Year-Old Man With Relapsed Multiple Myeloma
• Anthracycline Therapy in a 67-Year-Old Man With Multiple Myeloma Who Has Relapsed After ASCT

Imatinib Resistance in the Treatment of Chronic Myeloid Leukemia: Current Management Options and Emerging Therapies

Modules

• Imatinib Resistance in the Treatment of Chronic Myeloid Leukemia: Current Management Options and Emerging Therapies

Navigating Multiple Pathways: Evolving Options and Future Directions in Targeted Therapies

Modules

• Clinical Evidence: What Have We Learned From Targeting EGFR?
• Multitargeted Tyrosine Kinase Inhibitors: When Are More Targets Necessary?
• Targeting the Tumor Microenvironment: How Is It Useful?

CCO Slidesets

• Clinical Evidence: What Have We Learned From Targeting EGFR?
• Multitargeted Tyrosine Kinase Inhibitors: When Are More Targets Necessary?
• Targeting the Tumor Microenvironment: How Is It Useful?

Optimal Treatment of Locally Advanced/Metastatic Pancreatic Cancer: Current Progress and Future Challenges

Modules

• Progress in Pancreatic Cancer: Where Are We Now and Where Must We Go?
• Optimal Treatment of Advanced/Metastatic Pancreatic Cancer: Current Progress and Future Challenges

CCO Slidesets

• Advances in Pancreatic Cancer

Proceedings of the 17th International Prostate Cancer Update Meeting

Modules

• Epidemiology, Screening, Prevention, and Biomarkers
• Complementary/Alternative Medicine and Testosterone Replacement Therapy
• Treatment of Localized Disease
• Treatment of Advanced or Hormone-Refractory Disease
• Risk Stratification and Management of High-Risk Patients
• New Techniques and Management Options for Disease and Treatment Complications

Treatment Advances in Multiple Myeloma: Management of Challenging Clinical Scenarios

Modules

• Novel Therapies and Risk-Stratified Approaches for Challenging Patients With Multiple Myeloma

Interactive Case Challenges

• Treatment of Multiple Myeloma in a 63-Year-Old Male With Renal Insufficiency
• Management of an Older Multiple Myeloma Patient With Extensive Bony Disease and Multiple Cytogenetic Abnormalities

Management of Recurrent Epithelial Ovarian Cancer: Current Standards and Novel Approaches

Virtual Presentations

• Management of Recurrent Epithelial Ovarian Cancer: Therapeutic Approaches for the Relapsed Platinum-Resistant Patient
• Management of Recurrent Epithelial Ovarian Cancer: Current Standards in Patients With Platinum-Sensitive Disease
• Management of Recurrent Epithelial Ovarian Cancer: Future Directions and New Frontiers in Individualized Therapeutic Approaches

CCO Slidesets

• Current Approaches and Future Directions in the Treatment of Platinum-Sensitive or Platinum-Resistant Recurrent Ovarian Cancer

New Options for Renal Cell Carcinoma

CCO Slideset

• New Options for Renal Cell Carcinoma
• CCO Slideset – New Options for Renal Cell Carcinoma

Clinical Issues and Future Directions in Hematologic Malignancies

Virtual Presentations

• Clinical Issues and Future Directions in Hematologic Malignancies: Multiple Myeloma
• CCO Slideset – Clinical Issues and Future Directions in Hematologic Malignancies: Multiple Myeloma
• Clinical Issues and Future Directions in Hematologic Malignancies: Non-Hodgkin’s Lymphoma
• CCO Slideset – Clinical Issues and Future Directions in Hematologic Malignancies: Non-Hodgkin’s Lymphoma
• Clinical Issues and Future Directions in Hematologic Malignancies: Myelodysplastic Syndromes and Acute Leukemias
• CCO Slideset – Clinical Issues and Future Directions in Hematologic Malignancies: Myelodysplastic Syndrome and Acute Leukemias
• Clinical Issues and Future Directions in Hematologic Malignancies: Chronic Myeloid Leukemia
• CCO Slideset – Clinical Issues and Future Directions in Hematologic Malignancies: Chronic Myeloid Leukemia
• Clinical Issues and Future Directions in Hematologic Malignancies: Chronic Lymphocytic Leukemia
• CCO Slideset – Clinical Issues and Future Directions in Hematologic Malignancies: Chronic Lymphocytic Leukemia

Innovative Approaches to Treating Metastatic Breast Cancer: Patient Selection, Effective Combination Regimens, and Overcoming Resistance

View Virtual Presentations on these topics

Modules

• Molecular Classes of Breast Cancer and Their Clinical Implications for Advanced Disease
• New Therapeutic Development Approaches to Metastatic Human Breast Cancers: Trastuzumab Update
• The Use of Antiangiogenic Agents in the Treatment of Breast Cancer
• Overcoming Taxane Resistance in Metastatic Breast Cancer

Acute Lymphocytic Leukemia: Disease Overview and Treatment Options

Modules

• The Development and Diagnosis of Acute Lymphocytic Leukemia
• Treatment Strategies for Acute Lymphocytic Leukemia
• Individualized Strategies for the Management of Acute Lymphocytic Leukemia: Implications for Therapy

CCO Slideset

• Acute Lymphocytic Leukemia: Disease Overview and Treatment Options

Targeted Therapies in the Treatment of Non-Small-Cell Lung Cancer

Modules

• Update on Targeted Therapies in Advanced NSCLC

Interactive Case Challenges

• A 40-Year-Old Female Nonsmoker Diagnosed With Adenocarcinoma Consistent With Primary Non-Small-Cell Lung Cancer
• Management of a 50-Year-Old Male Smoker With Advanced Non-Small-Cell Lung Cancer
• Management of a 48-Year-Old Smoker With NSCLC

CCO Slideset

• Targeted Therapies in the Treatment of Advanced NSCLC

Treatment of Chronic Myeloid Leukemia

Module

• Current Treatment Options for Chronic Myelogenous Leukemia

Interactive Case Challenges

• Management of a 50-Year-Old Female With High-Risk CML
• A 45-Year-Old Woman With CML Who Is Intolerant of Imatinib
• Management of a 39-Year-Old Male With Intermediate-Risk, Chronic-Phase CML

Targeting Metastatic Colorectal Cancer: A Focus on Recent Advances

Modules

• Biology of Tumor Growth and Molecular Targets in Metastatic Colorectal Cancer
• Advances in the Management of Metastatic Colorectal Cancer

CCO Slidesets

• Targeting Metastatic Colorectal Cancer: A Focus on Recent Advances

Patient Management Strategies for Hard-to-Treat Lymphomas

Virtual Presentations

• Patient Management Strategies for Hard-to-Treat Lymphomas
• CCO Slideset – Patient Management Strategies for Hard-to-Treat Lymphomas

On-Demand Teleconference

• Patient Management Strategies for Hard-to-Treat Lymphomas

Utilization of Prognostic and Prediction Tools for the Management of Breast Cancer

Modules

• Utilizing Prognostic and Prediction Tools for the Management of Breast Cancer

Interactive Cases

• 41-Year-Old, Premenopausal Woman With Fertility Concerns Diagnosed With Breast Cancer
• A 63-Year-Old Postmenopausal Woman With ER-Positive, Node-Negative, Stage I Breast Cancer
• Treatment of Infiltrating Ductal Carcinoma in a Premenopausal Patient With Stage I Breast Cancer

New Clinical Insights and Treatment Developments in Head and Neck Cancer

Modules

• Changing Paradigms in the Treatment of Squamous Cell Carcinoma of the Head and Neck

Interactive Case Challenges

• Management of a 59-Year-Old Male With Locoregionally Advanced Hypopharynx Cancer
• Adjuvant and Relapsed Disease Treatment for Locally Advanced Oropharyngeal Carcinoma in a 57-Year-Old Male
• Treatment of a 37-Year-Old Female With Locally Advanced Tonsillar Squamous Cell Carcinoma

Management of Cardiotoxicity Issues Associated With Breast Cancer Therapy

Virtual Presentations

• Management of Cardiotoxicity Issues Associated With Breast Cancer Therapy
• CCO Slideset – Management of Cardiotoxicity Associated With Breast Cancer Therapy

On-Demand Teleconference

• Management of Cardiotoxicity Issues Associated With Breast Cancer Therapy

Treatment of Cutaneous T-Cell Lymphoma: Focus on Relapsed/Refractory Disease

Virtual Presentations

• Treatment of Cutaneous T-Cell Lymphoma: Focus on Relapsed/Refractory Disease
• CCO Slideset – Treatment of Cutaneous T-Cell Lymphoma: Focus on Relapsed/Refractory Disease

New Therapeutic Options for Renal Cell Carcinoma

Modules

• Treatment Options for Renal Cell Carcinoma: Past, Present, and Future

CCO Slidesets

• Understanding Advanced Renal Cell Carcinoma: Rethinking Standard Approaches to Treatment (Presented by : David P. Wood, MD)
• Novel Agents: Unique Therapeutic Targets in Advanced Renal Cell Carcinoma (Presented by: Nicholas J. Vogelzang, MD)
• What’s Next? Unanswered Questions in Renal Cell Carcinoma (Presented by: Brian I. Rini, MD)

Recent Advances in Treatment Options for Multiple Myeloma: A Focus on Frontline Therapy

Modules

• Pathogenesis of Multiple Myeloma: Rationale for New and Novel Therapies
• Recent Advances in Treatment Options for Multiple Myeloma: A Focus on Frontline Therapy

Slides

• Advances in Frontline Treatment of Multiple Myeloma

Treatment Options for Postmenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer

Virtual Presentations

• Treatment Options for Postmenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer: Overview of Aromatase Inhibitors
• CCO Slideset – Treatment Options for Postmenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer: Overview of Aromatase Inhibitors
• Treatment Options for Postmenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer: Recent Trials and Future Directions
• CCO Slideset – Treatment Options for Postmenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer: Recent Trials and Future Directions

Audio Discussion

• Teleconference: Treatment Options for Postmenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer

Treatment Options for Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer

Virtual Presentations

• Treatment Options for Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer: An Overview
• CCO Slideset – Treatment Options for Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer: An Overview
• Treatment Options for Premenopausal Women With Breast Cancer: Ongoing Studies
• CCO Slideset – Treatment Options for Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer: Ongoing Studies

Audio Discussion

• Treatment Options for Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer

Recent Advances With Targeted Therapies in the Treatment of Breast Cancer

Modules

• Recent Advances With Targeted Therapies in the Treatment of Breast Cancer— Oncogene Signaling and Antiestrogen Resistance: Mechanisms and Clinical Trial Implications in Breast Cancer
• Recent Advances With Targeted Therapies in the Treatment of Breast Cancer—Antiangiogenic Therapy in Breast Cancer: Where Do We Go From Here?
• Recent Advances With Targeted Therapies in the Treatment of Breast Cancer— Targeting HER2 in Breast Cancer: Current Results and Future Potential
• Recent Advances With Targeted Therapies in the Treatment of Breast Cancer: Novel Therapeutic Targets in the Treatment of Breast Cancer—Focus on Epothilones

CCO Slidesets

• Oncogene Signaling and Antiestrogen Resistance: Mechanisms and Clinical Trial Implications in Breast Cancer
• Targeting HER2 in Breast Cancer: Current Research and Future Potential
• Antiangiogenic Therapy for Breast Cancer: Where Do We Go From Here?
• Epothilones in Breast Cancer

Circulating Tumor Cells: Emerging Biology and Practical Application

On-Demand Video Conference

• Circulating Tumor Cells: Emerging Biology and Practical Application
• CCO Slideset – Circulating Tumor Cells: Emerging Biology and Practical Application

Recent Advances in Targeted Therapies for Renal Cell Carcinoma

Modules

• The von Hippel-Lindau Tumor Suppressor Protein and Renal Cell Cancer: Implications for Therapy
• Targeted Therapies for the Treatment of Renal Cell Carcinoma

Beyond Taxane Therapy: The Emerging Role of Epothilones in Metastatic Breast Cancer

Modules

• Treatment Options After Hormone, Anthracycline, and Taxane Therapy in Advanced/Metastatic Breast Cancer
• Epothilones: Development, Preclinical Data, and Pharmacology
• Activity of Epothilones in Breast Cancer and Other Tumor Types
• Combined Module—Beyond Taxane Therapy: The Emerging Role of Epothilones in Metastatic Breast Cancer

Downloadable PowerPoint Slides

• Treatment Options After Hormone, Anthracycline, and Taxane Therapy in Advanced/Metastatic Breast Cancer
• Epothilones: Development, Preclinical Data, and Pharmacology
• Activity of Epothilones in Breast Cancer and Other Tumor Types

Changing the Outcome of CLL: Prognostic Tools and Novel Therapeutic Modalities

Modules

• Diagnostic and Post-treatment Detection Factors
• Treatment Issues in CLL

Downloadable PowerPoint Slides

• Recent Developments in the Identification of Biologic Markers and Prognostic Factors in CLL
• Undetectable Minimal Residual Disease: An Attainable Goal in CLL Treatment
• Immunotherapy and Chemoimmunotherapy in the Treatment of CLL
• Consolidation Strategies With Monoclonal Antibodies in the Treatment of CLL
• Treatment of B-Cell Malignancies: Current Standard of Care